EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY 4.0

Long-term complete remission of metastatic combined hepatocellular-cholangiocarcinoma with nivolumab following failure of targeted therapies: a case report

Young Mi Hong

Frontiers in Oncology · 14.04.2026 · 16

DOI: 10.3389/fonc.2026.1515511 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Frontiers in Oncology, online erschienen am 14.04.2026. Verfasst von Young Mi Hong. Beteiligte Einrichtung: Department of Internal Medicine, Pusan National University School of Medicine, Yangsan, Republic of Korea. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Combined hepatocellular-cholangiocarcinoma (cHCC-CCA) is a rare and aggressive primary liver malignancy with limited treatment options and poor prognosis. We report the case of 33-year-old male with chronic hepatitis B who underwent hepatectomy and pulmonary metastasectomy for HCC with lung metastases. Histological examination revealed cHCC-CCA. However, new lung and chest wall metastases emerged and sorafenib and regorafenib was administered and failed to control tumor progression. The patient was then treated with nivolumab, which led to a complete remission (CR) after 37 weeks. Remarkably, this response has been sustained for over six years without any immune-related adverse events. This case represents a rare case of long-term CR in metastatic cHCC-CCA following treatment with nivolumab after failure of tyrosine kinase inhibitors, suggesting that nivolumab may represent a promising therapeutic option for this challenging malignancy.

Schlagwörter

Stichwörter der Autor:innen

combined hepatocellular-cholanciocarcinoma (cHCC-CCA)immunotherapymetastatic cancernivolumabtargeted therapy resistance

Autor:innen und Institutionen

  • Department of Internal Medicine, Pusan National University School of Medicine, Yangsan, Republic of Korea.
  • Liver Center, Pusan National University Yangsan Hospital, Yangsan, Republic of Korea.

Zitieren

APA

Hong, Y. M. (2026). Long-term complete remission of metastatic combined hepatocellular-cholangiocarcinoma with nivolumab following failure of targeted therapies: a case report. Frontiers in Oncology, 16. https://doi.org/10.3389/fonc.2026.1515511

Vancouver

Hong YM. Long-term complete remission of metastatic combined hepatocellular-cholangiocarcinoma with nivolumab following failure of targeted therapies: a case report. Frontiers in Oncology. 2026;16. doi:10.3389/fonc.2026.1515511

BibTeX
@article{Hong2026,
  author = {Hong, Young Mi},
  title = {Long-term complete remission of metastatic combined hepatocellular-cholangiocarcinoma with nivolumab following failure of targeted therapies: a case report},
  journal = {Frontiers in Oncology},
  year = {2026},
  volume = {16},
  doi = {10.3389/fonc.2026.1515511}
}
Kostenlos starten →